Phase 3 Pancreatic Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are at least 18 years old and have agreed to take part by signing a consent form
- People whose general health and ability to carry out daily activities meets a certain level, known as an ECOG score of 0 or 1 — meaning fully active or restricted in strenuous activity only (confirm with trial site)
- People who have been diagnosed with pancreatic ductal adenocarcinoma (a specific type of pancreatic cancer) confirmed by laboratory testing of tissue, and who have had surgery aimed at removing all or most of the cancer
- People who show no signs of the cancer returning or spreading after surgery
- People who have received chemotherapy involving more than one drug, either before surgery, after surgery, or both
- People who finished their most recent cancer treatment within the past 12 weeks
- People whose bone marrow, liver, kidneys, and blood clotting are all functioning at an adequate level (confirm with trial site)
- People who have had testing done to determine whether a specific gene change called a RAS mutation is present in their cancer
- People who are able to swallow and take oral (by mouth) medications
Who may not be able to join:
- People who have previously received any treatment that directly targets the RAS protein, such as RAS inhibitors or degraders
- People who have any condition that could interfere with taking or absorbing the study drug by mouth
- People who have had a major surgical procedure within 28 days before being enrolled in the trial
- People who are unable or unwilling to attend required visits or complete required procedures as set out in the trial plan
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 1-844-2-REVMED
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Disease-Free Survival (DFS) per Investigator
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.